The summer calm is grinding to a halt as members of Congress have returned to D.C. for what is sure to be a busy legislative sprint that could potentially impact all sectors of the biotech industry. The State of Play The House adjourned two weeks ago after laying the groundwork (on a party-line... Continue Reading
News
News and policy insights from NCLifeSci
Rep. Donna McDowell White welcomes attendees NCBIO President Laura Gunter Scott Uknes, Ph.D., co-founder and co-CEO of AgBiome John Fleming, a farmer and partner with Fleming Brothers Farms, LLC in Halifax Sinnovatek President and CEO Michael Druga T. Y. Baker and... Continue Reading
NC Secretary of Commerce Machelle Sanders North Carolina Secretary of Commerce Machelle Baker Sanders encouraged the life sciences industry to be an active participant in shaping the state’s economic plan during the quarterly meeting of the NCBIO Biotech Manufacturer’s Forum held... Continue Reading
Representatives from G1 Therapeutics, United Therapeutics and Thermo Fisher Scientific shared insights from their companies with members of the North Carolina General Assembly's Life Science Caucus on during its meeting held Wednesday, July 21. Caucus co-chairs Sen. Mike Woodard, Sen.... Continue Reading
When it comes to creating lab space for a new or established business, getting your team together early and allowing plenty of time to plan are the keys to success, according to panelists assembled for NCBIO’s Lab Space Forum held online Tuesday, July 13. The pandemic has caused... Continue Reading
Laura Gunter Laura Gunter, M.B.A, has been selected as the new president of NCBIO, the N.C. Biosciences Organization, succeeding longtime president Sam Taylor who died in February. Gunter has served as the organization’s executive vice president since 2020 and has filled the executive... Continue Reading
Vaccine patent waiver breaks faith with American companies, stifles innovation NCBIO is extremely disappointed that the Biden administration has chosen to support waiving critical intellectual property protections for U.S. COVID-19 vaccines. This decision, known as a TRIPS waiver,... Continue Reading